Showing results (141-150 of 191) with videos related to

Sort By:
Pageof 20
Annals of Surgery|May 25, 2007
CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancerJeffrey A Norton, Christine M Ham, Jacques Van Dam, et al.
Cancer Research|September 23, 2010
AXL is an essential factor and therapeutic target for metastatic ovarian cancerErinn B Rankin, Katherine C Fuh, Tiffany E Taylor, et al.
The American Journal of Surgical Pathology|April 9, 2008
Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implicationsWilliam M Rogers, Erika Dobo, Jeffrey A Norton, et al.
Gynecologic Oncology|October 21, 2005
Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomasLindsay A Brown, Julie Irving, Robin Parker, et al.
Histopathology|June 11, 2024
Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low- and high-stage tumoursAustin McHenry, Kelly Devereaux, Emily Ryan, et al.
British Journal of Cancer|February 24, 2006
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancersC A Hamilton, M K Cheung, K Osann, et al.
Scientific Reports|July 4, 2020
PAM staining intensity of primary neuroendocrine neoplasms is a potential prognostic biomarkerTimothy M Horton, Vandana Sundaram, Christine Hye-Jin Lee, et al.
The American Journal of Surgical Pathology|February 10, 2021
Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From CarcinosarcomaSoufiane El Hallani, Rupali Arora, Douglas I Lin, et al.
Gastroenterology|June 1, 2015
KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon CancersEvan C Chen, Taylor A Karl, Tomer Kalisky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Copy number aberrations in benign serous ovarian tumors: a case for reclassification?Sally M Hunter, Michael S Anglesio, Raghwa Sharma, et al.
Pageof 20